Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
UNII: | 71IA9S35AJ |
InChI Key | WUWDLXZGHZSWQZ-WQLSENKSSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C15H14N2O |
Molecular Weight | 238.29 |
AlogP | 3.12 |
Hydrogen Bond Acceptor | 1.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 44.89 |
Molecular species | NEUTRAL |
Aromatic Rings | 2.0 |
Heavy Atoms | 18.0 |
Primary Target | |
---|---|
fms related receptor tyrosine kinase 1 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Kinase
Protein Kinase
TKL protein kinase group
TKL protein kinase STKR family
TKL protein kinase STKR Type 1 subfamily
|
- | 1200-1810 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Abl family
|
- | 11000 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase FGFR family
|
- | 4200-50000 | - | - | 87 | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase PDGFR family
|
- | 68-37900 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Ret family
|
- | 170 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Src family
|
- | 16400 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Syk family
|
- | 20700 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase VEGFR family
|
- | 13-12900 | - | - | 40-40 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Melanoma | 2 | D008545 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Multiple Myeloma | 2 | D009101 | ClinicalTrials |
Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
Mesothelioma | 2 | D008654 | ClinicalTrials |
Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Rectal Neoplasms | 1 | D012004 | ClinicalTrials |
Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Colonic Neoplasms | 1 | D003110 | ClinicalTrials |
Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 194413-58-6 |
ChEBI | 91083 |
ChEMBL | CHEMBL276711 |
DrugBank | DB06436 |
FDA SRS | 71IA9S35AJ |
Guide to Pharmacology | 5056 |
PDB | X2M |
PubChem | 5329098 |
SureChEMBL | SCHEMBL19571 |
ZINC | ZINC000012410091 |